Preview

Cardiac Rhythm Management Devices Market in US and Europe 2020

Satisfactory Essays
Open Document
Open Document
1823 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Cardiac Rhythm Management Devices Market in US and Europe 2020
Market Snapshot: Cardiac Rhythm Management Devices 2006 to 2020 – US and Europe
By - GBI Research
Summary
Research’s report: “Cardiac Rhythm Management Devices 2006 to 2020 – US & Europe” provides quantitative analysis of the four cardiac rhythm management devices market segments: cardiac resynchronization therapy devices, implantable cardioverter defibrillators, implantable loop recorders and pacemakers. The analysis includes market size data by revenue and volume over the 2006–2020 periods for the following countries: US, Germany, France, Italy, UK and Spain. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Research’s team of industry experts.
Scope
Information on market size for the four cardiac rhythm management devices market segments: cardiac resynchronization therapy devices, implantable cardioverter defibrillators, implantable loop recorders and pacemakers
Annualized sales data by revenue for the 2006–2020 period and company share data by revenue for 2013
Annualized sales data by volume for the 2006–2020 period
Coverage of key geographies: China US, Germany, France, Italy, UK and Spain
Reasons to Buy
Derive actionable insights from value-volume relationships
Analyze value-volume relationships and provide direction to marketing and sales strategies
Develop market-entry and market-expansion strategies
Identify the key players best positioned to take advantage of opportunities in the US and European markets
View Complete Report @ http://www.lifescienceindustryresearch.com/market-snapshot-cardiac-rhythm-management-devices-2006-to-2020-us-and-europe.html .
Table of Contents
1 Table of Contents 1
1.1 List of Tables 4
1.2 List of Figures 6
2. GBI Research Report Guidance 8
3 Definitions 8
3.1 Cardiac Rhythm Management Devices 8
3.2 Cardiac Resynchronization Therapy Devices 9
3.2.1 Cardiac Resynchronization Therapy – Defibrillators 9
3.2.2 Cardiac Resynchronization

You May Also Find These Documents Helpful

  • Better Essays

    Case Study 1

    • 2103 Words
    • 9 Pages

    McGrady, Elizabeth, Sue Conger, Sandra Blanke, and Brett J.L. Landry. "Emerging Technologies in Healthcare: Navigating Risks, Evaluating Rewards." Journal of Healthcare Management 55.5 (2010): 353-364. Print.…

    • 2103 Words
    • 9 Pages
    Better Essays
  • Satisfactory Essays

    NR439 RRL1 Form

    • 439 Words
    • 3 Pages

    The following questions pertain to: Schwarz, K., Mion, P., Hudock, D., & Litman, G. (2008). Telemonitoring of heart failure patients and their caregivers: A pilot randomized controlled study. Progress in Cardiovascular Nursing, 23(1), 18–26.…

    • 439 Words
    • 3 Pages
    Satisfactory Essays
  • Good Essays

    NR439 RRL2 Form

    • 387 Words
    • 2 Pages

    The following questions pertain to: Schwarz, K., Mion, P., Hudock, D., & Litman, G. (2008). Telemonitoring of heart failure patients and their caregivers: A pilot randomized controlled study. Progress in Cardiovascular Nursing, 23(1), 18–26.…

    • 387 Words
    • 2 Pages
    Good Essays
  • Good Essays

    Week2Assignment 322

    • 2243 Words
    • 11 Pages

    In a pilot study evaluating the use of a new drug to lower resting heart rates (HR) of patients, the following data was recorded:…

    • 2243 Words
    • 11 Pages
    Good Essays
  • Good Essays

    Proof

    • 2418 Words
    • 10 Pages

    "Global Standardization" may be an option because customization of the pacemaker is not needed. It is a universal product. Costs will be low. Aggressive pricing can be used. The drawback is a competitor may create a better product through evolution.…

    • 2418 Words
    • 10 Pages
    Good Essays
  • Powerful Essays

    Marketing: Aradia

    • 4621 Words
    • 14 Pages

    References: Future Watch: Consumer Interest in Technology for Health Monitoring. 2012. Euromonitor. Accessed February 20. http://www.portal.euromonitor.com.proxy.library.carleton.ca/Portal/Pages/Search/SearchResultsList.aspx…

    • 4621 Words
    • 14 Pages
    Powerful Essays
  • Better Essays

    The patient monitoring market will potentially grow because of the costs of managing the aging patients. The increase in the aging population will end in the increase requirement for health care services in general, and this includes monitoring devices. Remote patient monitoring segments and Tele-health will be needed more with in-patient care units to extensive applications in hospitals, and ambulatory care. “The expanding incidence and diagnosis of diabetes will promote greater precautionary testing and data acquisition from patient monitors into paperless charting systems (EMR’s)” (S. Munshi, 2008). The usage of Electronic Medical Record’s will not only be a great driver for spending in the patient…

    • 1106 Words
    • 5 Pages
    Better Essays
  • Good Essays

    Hcs 212 Article Review

    • 794 Words
    • 4 Pages

    While reviewing the article Health Care Technology Today by Authors Hargrove L, Simon AM, Young AJ., Martinez-Perez B, De Le Torre-Diez I, and Lopez-Coronado M. The writer was able to gain knowledge on advances and proposals in health care technology. The advances in prosthetic limbs, blood pressure and heart-rate monitoring, Health sensors and the applications. Being that the writer has been working in the medical field, the writer found these advances in technology very interesting. The writer is a Certified Nursing Assistant and has experience working with residents/patients with prosthetic legs, hypotension and hypertension that would benefit from…

    • 794 Words
    • 4 Pages
    Good Essays
  • Good Essays

    By informing our service area and the general public of our competent and well educated cardiology specialists and elegant state-of-the-art amenities through grassroots outlets and direct contact, {Insert} will quickly gain more market share. We will also provide benchmarked customer service and flexibility.…

    • 546 Words
    • 2 Pages
    Good Essays
  • Good Essays

    Read the case of “We’ve Got Rhytm! Medtronic Cardiac Pacemaker Business”. Please answer the following questions:…

    • 881 Words
    • 4 Pages
    Good Essays
  • Good Essays

    The legacy of Medtronic Corporation, the company that created the cardiac pacemaker industry, is a proud one. Starting from its earliest pacemakers, which had to be carried outside the body, Medtronic had achieved dramatic improvements in the functionality, size and reliability of these devices. In so doing it had extended the lives, and improved the quality of life, for hundreds of thousands of people in whom pacemakers had been implanted. The pacemaker has been designated as one of the ten most outstanding engineering achievements in the world over the past 50 years, along with the digital computer and the Apollo 11 moon landing. 1 Medtronic, which in 1995 booked operating profit of $300 million on revenues of $1.7 billion, had been founded in 1957 in Minneapolis, Minnesota by Earl Bakken, a researcher and inventor who had to his credit patents on several of the crucial technologies that led to the modern heart pacemaker. Pacemakers were small, battery-powered devices which, when implanted within a patient, helped a malfunctioning heart to beat in a steady, fixed rhythm. Because Medtronic was the first entrant into the pacemaker field and built a strong technological lead, it enjoyed a substantial portion (over 70%) of the market share for cardiac pacing through the 1960s. Building upon Medtronic’s legacy of leadership was not easy, however. In the face of increasing competition, rapid technological change and tightening market and regulatory demands for product quality, Medtronic saw its market share cut by more than half between 1970 and 1986. Though it had invested heavily in technology and product development over this period, much of that investment had been unproductive. Many projects failed to produce product designs that could be launched competitively, and the features and functionality of most of the products the company was able…

    • 8613 Words
    • 35 Pages
    Good Essays
  • Good Essays

    As the story of the Sole Remaining Supplier was told to me, the Board conversation went pretty much the way the case describes it. Legal was saying, "This is a time bomb waiting to happen. Why are we even talking about this?" Engineering was bemoaning the lack of standards for testing the electronics of pacemakers, and the majority of the Board understood that they had a problem with no easy solution.…

    • 365 Words
    • 2 Pages
    Good Essays
  • Satisfactory Essays

    All Market Research announces that a new market research report is available in its catalogue:”http://www.allmarketresearch.com/wiki/apheresis-equipment-market-plasmapheresis-photopheresis-apheresis-in-neurological-renal-hematological-diseases-centrifugation-membrane-filtration-apheresis-machines-and-disposable-kits-global-industry-analysis-size-share-growth-trends-.php“…

    • 623 Words
    • 3 Pages
    Satisfactory Essays
  • Powerful Essays

    Medtronic

    • 940 Words
    • 4 Pages

    Founded in 1949, Medtronic is the world’s largest Medical Technology Company and also a Fortune 500 company. Medtronic specializes in medical devices and therapies to treat over 30 chronic diseases. With headquarters located in Fridley, Minnesota the company has over 41,000 employees bringing in annual revenue of $14.599 Billion dollars. (1) Due to patient’s positive feedback and the results of Medtronic, Co-founder Earl Bakken came up with a mission statement half a century ago that continues to serve as an ethical framework and inspirational goal for employees around the world today. Medtronic builds on the areas of biomedical engineering through education and knowledge. They will avoid participating where they cannot make unique and worthy contributions. Instead, Medtronic strives to be the unsurpassed standard of comparison and to be recognized as a company of dedication, honesty, integrity, and service.…

    • 940 Words
    • 4 Pages
    Powerful Essays
  • Satisfactory Essays

    totally artificial heart

    • 1139 Words
    • 5 Pages

    SynCardia Systems, Inc. is formed by Dr. Marvin J. Slepian along with biomedical engineer Richard G. Smith, MSEE, CEE and cardiothoracic surgeon Dr. Jack Copeland with private funding to commercialize the CardioWest Total Artificial Heart and to continue the IDE clinical study.…

    • 1139 Words
    • 5 Pages
    Satisfactory Essays